Bank of Nova Scotia
ONCY

Bank of Nova Scotia’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Bank of Nova Scotia’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-250,000
Closed -$120K – 715
2015
Q2 		$120K Hold
250,000
– – ﹤0.01% 597
2015
Q1 		$186K Sell
250,000
-250,000
-50% -$160K ﹤0.01% 577
2014
Q4 		$276K Hold
500,000
– – ﹤0.01% 475
2014
Q3 		$286K Hold
500,000
– – ﹤0.01% 458
2014
Q2 		$642K Hold
500,000
– – ﹤0.01% 324
2014
Q1 		$905K Hold
500,000
– – ﹤0.01% 311
2013
Q4 		$781K Buy
+500,000
New +$1.13M ﹤0.01% 336

Other funds holding ONCY

VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Bank of Nova Scotia's ONCY Position: Q3 2015 in Review

Bank of Nova Scotia sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q3 2015, closing a stake of 250,000 shares — an estimated $120K sold.

Bank of Nova Scotia first reported a position in ONCY in Q4 2013 and held it in 7 quarters. The position peaked at $905K in Q1 2014. 27 funds tracked by Wall St. Rank hold ONCY as of Q3 2015.

  • Bank of Nova Scotia reported no remaining ONCOLYTICS BIOTECH INC position as of Q3 2015 after selling out during the quarter.
  • Bank of Nova Scotia sold 250,000 ONCOLYTICS BIOTECH INC shares in Q3 2015, an estimated $120K.
  • Bank of Nova Scotia first reported a position in ONCOLYTICS BIOTECH INC in Q4 2013 and held it in 7 quarters.
  • Bank of Nova Scotia's ONCOLYTICS BIOTECH INC position peaked at $905K in Q1 2014.
  • 27 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q3 2015.

Based on Bank of Nova Scotia's 13F filing for Q3 2015, filed 13 Nov 2015.